Clinical Trials Directory

Trials / Sponsors / Braeburn Pharmaceuticals

Braeburn Pharmaceuticals

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedBuprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
Chronic Lower Back Pain, Chronic Pain
Phase 32016-09-01
CompletedStudy to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242
Schizophrenia
Phase 12016-06-20
CompletedSafety and Tolerability of Risperidone Implants
Schizophrenia
Phase 32016-04-01
CompletedClinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Op
Opioid Use Disorders
Phase 32015-12-01
CompletedLong-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
Opioid Use Disorder
Phase 32015-11-01
CompletedA Multiple Dose Opioid Challenge Study
Moderate or Severe Opioid Use Disorder
Phase 22015-10-01
CompletedStudy in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-
Schizophrenia, Schizo-affective Disorder
Phase 22015-10-01
CompletedPhase II Pharmacokinetics Study of CAM2038
Opioid Use Disorder, Chronic Pain
Phase 22015-02-01